A wound to a warfighter presents problems in terms of immediate combat effectiveness and possible incapacitation due to loss of fluids, or contamination of the wound by pathogens, toxins, or other incapacitating agents. Wound management and combat effectiveness benefits when the healing process can begin immediately. A system that would allow the warfighter to self-treat the wound in isolation or austere environments, without fear of doing additional harm, would provide the most rapid means maintain persistence in combat and better long term recovery. Stericon, Inc has a system that could provide the warfighter with such a system through the use of a wound care solution that we have established is antimicrobial, and is expected to be effective, safe, and easy to use by non-medical personnel to serve as a wound healing accelerant. Stericon, Inc seeks to develop and commercialize a wound healing accelerant for use by soldiers that is safe and easy to use, low cost, and effective at maintaining the combat effectiveness of the individual. This system could be used in households and hospitals to inhibit the spread of infection while promoting the healing of acute and chronic wounds. The safety of the system is attractive for these markets in that no special or medical training is required to use the product, and the product is not dangerous even if misused
